# Aclaris Therapeutics, Inc.: funding, H-1B (November 2026)

Registers read on November 19, 2026.

Aclaris Therapeutics, Inc. (Pennsylvania) appears in 3 public registers SpecStream reads: 8 Form D filings, 3 certified H-1B and PERM cases and 5 SEC annual and quarterly reports; the newest record is dated February 26, 2026, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 3
- Newest record: February 26, 2026
- State: Pennsylvania

## Form D filings (SEC)

8 Form D filings, newest December 4, 2024.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/aclaris-therapeutics-inc-1557746) | December 4, 2024 | $80 million sold of $80 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557746/000123191924000093/0001231919-24-000093-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/aclaris-therapeutics-inc-1557746) | April 8, 2020 | $11 million sold of $11.4 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557746/000123191920000022/0001231919-20-000022-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/aclaris-therapeutics-inc-1557746) | August 13, 2018 | $10 million sold of $12.5 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557746/000119248218000391/0001192482-18-000391-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/aclaris-therapeutics-inc-1557746) | August 14, 2017 | $10 million sold of $12.5 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557746/000119248217000228/0001192482-17-000228-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/aclaris-therapeutics-inc-1557746) | June 14, 2016 | $20 million sold of $20 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557746/000155774616000002/0001557746-16-000002-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/aclaris-therapeutics-inc-1557746) | September 11, 2015 | $40 million sold of $40 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557746/000155774615000001/0001557746-15-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/aclaris-therapeutics-inc-1557746) | October 8, 2014 | $10.6 million sold of $21.3 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557746/000155774614000001/0001557746-14-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/aclaris-therapeutics-inc-1557746) | September 10, 2012 | $20.9 million sold of $20.9 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557746/000155774612000002/0001557746-12-000002-index.htm) |

- [Aclaris Therapeutics, Inc.](https://specstream.ai/data/form-d/company/aclaris-therapeutics-inc-1557746)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1557746&type=D)

## H-1B and PERM certifications (Department of Labor)

3 certified H-1B and PERM cases, newest February 4, 2026.

- EIN: 46-0571712

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Scientist](https://specstream.ai/data/hiring/employer/aclaris-therapeutics-inc-460571712) | February 4, 2026 | H-1B, 2 cases, $55.9 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q2.xlsx) |
| [Principal Scientist](https://specstream.ai/data/hiring/employer/aclaris-therapeutics-inc-460571712) | June 20, 2023 | H-1B, 1 case, $89.4 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2023_Q3.xlsx) |

- [Aclaris Therapeutics, Inc.](https://specstream.ai/data/hiring/employer/aclaris-therapeutics-inc-460571712)

## Public company financials (SEC)

5 SEC annual and quarterly reports, newest February 26, 2026.

- SEC central index key (CIK): 1557746
- Industry: SIC 2834, Pharmaceutical preparations
- Filer category: Non-accelerated filer

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [10-K filed February 26, 2026](https://specstream.ai/data/public-companies/company/1557746-aclaris-therapeutics-inc) | February 26, 2026 | Revenue $7.8 million | [sec.gov](https://www.sec.gov/Archives/edgar/data/1557746/000110465926020540/0001104659-26-020540-index.htm) |

- [Aclaris Therapeutics, Inc.](https://specstream.ai/data/public-companies/company/1557746-aclaris-therapeutics-inc)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (Pennsylvania), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Pennsylvania

- [Pharmaceutical companies in Pennsylvania, United States](https://specstream.ai/data/businesses/pharmaceutical-companies/pennsylvania-united-states)
- [Mediators in Pennsylvania, United States](https://specstream.ai/data/businesses/mediators/pennsylvania-united-states)
- [Roofing contractors in Pennsylvania, United States](https://specstream.ai/data/businesses/roofing-contractors/pennsylvania-united-states)
- [Automation companies in Pennsylvania, United States](https://specstream.ai/data/businesses/automation-companies/pennsylvania-united-states)
- [Driving schools in Pennsylvania, United States](https://specstream.ai/data/businesses/driving-schools/pennsylvania-united-states)
- [Language schools in Pennsylvania, United States](https://specstream.ai/data/businesses/language-schools/pennsylvania-united-states)
